The National Health Strategy 2024-2030 is anticipated to drive substantial growth in Qatar’s medical device and digital health sectors. Forecasted by BMI, a Fitch Solutions company, the strategy is expected to enhance demand for advanced digital devices, products for non-communicable disease prevention (such as diagnostic imaging devices), and vaccination-related supplies. Launched in October, the strategy focuses on improving population health, service excellence, and health system resilience. It aims to build an integrated health system in Qatar, prioritizing clinical quality, sustainability, and innovation, with 300 projects targeting patient-centered pathways, healthcare digitization, and research. Projects include universal vaccination, occupational health, food safety, care model enhancements, health tourism, and workforce development.
BMI projects a steady 5.7% annual growth in Qatar’s medical device market, reaching QR1.1 billion ($298.6 million) by 2028. Growth is expected to be boosted in 2025 by increased oil output and investment, spurred by monetary policy shifts that will lift GDP growth by 2.2%. Government investment in healthcare will also sustain this growth long-term.
According to BMI, Qatar’s strategy will especially support orthopaedics and patient aids as the aging population’s needs increase; the UN Population Fund projects those over 60 to rise from 3.6% of Qatar’s population in 2020 to 20.3% by 2050. This demographic shift will drive demand for orthopaedic and patient aid devices, including hearing aids and pacemakers, a need further supported by Qatar’s expanding medical tourism sector.
Presently, orthopaedic products and patient aids represent only 7% and 10%, respectively, of Qatar’s total medical device market.
